Please login to the form below

Not currently logged in
Email:
Password:

Buyer found for Pfizer's Cork plant

Hovione, an international manufacturer of active pharmaceutical ingredients (APIs), has announced it is to buy Pfizer's Loughbeg site in Cork

Hovione, an international manufacturer of active pharmaceutical ingredients (APIs), has announced it is to buy Pfizer's Loughbeg site in Cork.

Hovione will employ between 70 and 80 staff at the Irish plant, leading to redundancies for several of the remainder of the 232 staff currently employed at the site.

"We have worked determinedly over the past 20 months to sell the Loughbeg API plant in order that our colleagues would be able to continue working here," said Paul Duffy Pfizer's vice president of manufacturing for Ireland and Singapore. "While we have been successful in preserving 70 to 80 positions and while some colleagues will opt for voluntary severance, unfortunately there will not be positions for all currently employed at the site and there will be some enforced redundancies."

Hovione will continue to provide manufacturing services for Pfizer as well as transferring products from its site in Loures, Portugal. The deal is scheduled to be complete by April 2009.

"We made clinical trial materials for over 40 drug candidates last year. We have been investing heavily in R&D for over six years and now have a strong development pipeline," said Miguel Calado, CFO at Hovione. "This site offers everything that our customers might want: large scale capacity, the highest standards, and in a location where tax benefits are available to them, along with a well trained, innovative workforce." 

17th December 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma
Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...

Infographics